StevenLMcCuneMD

PubMed

• Measures of functional status in older patients treated with palbociclib for advanced breast cancer.
  Cappelleri, J., Cuevas, J., Montelongo, M., Wang, Y., Karuturi, M., Blum, J., Patel, K., Telivala, B., McCune, S., Lakhanpal, S., Tripathy, D., Rocque, G.> ;Journal of Geriatric Oncology. 2024 Jan 1
• 1 citations
  Comparison of SP263 and 22C3 immunohistochemistry PD-L1 assays for clinical efficacy of adjuvant atezolizumab in non-small cell lung cancer: results from the randomize...
  Caicun Zhou, Minu K Srivastava, Hao Xu, Enriqueta Felip, Heather Wakelee, Nasser Altorki, Martin Reck, Rüdiger Liersch, Anna Kryzhanivska, Satoshi Oizumi, Hiroshi Tana...> ;Journal for Immunotherapy of Cancer. 2023 Oct 1
• 13 citations
  Nivolumab plus rucaparib for metastatic castration-resistant prostate cancer: results from the phase 2 CheckMate 9KD trial.
  Karim Fizazi, Margitta Retz, Daniel P Petrylak, Jeffrey C Goh, Jose Perez-Gracia, Louis Lacombe, Stefanie Zschäbitz, Mauricio Burotto, Hakim Mahammedi, Gwenaelle Gravi...> ;Journal for Immunotherapy of Cancer. 2022 Aug 1
• 21 citations
  VERONICA: Randomized Phase II Study of Fulvestrant and Venetoclax in ER-Positive Metastatic Breast Cancer Post-CDK4/6 Inhibitors - Efficacy, Safety, and Biomarker Resu...
  Geoffrey J Lindeman, Tharu M Fernando, Rebecca Bowen, Katarzyna J Jerzak, Xinni Song, Thomas Decker, Frances Boyle, Steve McCune, Anne Armstrong, Catherine Shannon, Gi...> ;Clinical Cancer Research. 2022 Aug 2
• 22 citations
  Telaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA Trial.
  Chung-Han Lee, Robert Motzer, Hamid Emamekhoo, Marc Matrana, Ivor Percent, James J Hsieh, Arif Hussain, Ulka Vaishampayan, Sandy Liu, Steven McCune, Vijay Patel, Monta...> ;Clinical Cancer Research. 2022 Aug 2
• 22 citations
  Phase II, Randomized Study of Spartalizumab (PDR001), an Anti-PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer.
  Caroline Even, Hung-Ming Wang, Shau-Hsuan Li, Roger K-C Ngan, Arunee Dechaphunkul, Li Zhang, Chia Jui Yen, Po Chung Chan, Somvilai Chakrabandhu, Brigette B.Y. Ma, Sueb...> ;Clinical Cancer Research. 2021 Dec 1
• 19 citations
  Standard-Dose Pembrolizumab Plus Alternate-Dose Ipilimumab in Advanced Melanoma: KEYNOTE-029 Cohort 1C, a Phase 2 Randomized Study of Two Dosing Schedules.
  Georgina V. Long, Caroline Robert, Marcus O. Butler, Félix Couture, Matteo S. Carlino, Steven J. O'Day, Victoria Atkinson, Jonathan Cebon, Michael P. Brown, Stéphane D...> ;Clinical Cancer Research. 2021 Jul 1
• 908 citations
  Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-...
  Howard Jack West, Michael McCleod, Maen A. Hussein, Alessandro Morabito, Achim Rittmeyer, Henry Jacob Conter, Hans-Georg Kopp, Davey B. Daniel, Steven L. McCune, Tarek...> ;The Lancet. Oncology. 2019 Jul 1
• 48 citations
  A recombinant human hemoglobin with anti-sickling properties greater than fetal hemoglobin.
  Dana N. Levasseur, Thomas M. Ryan, Michael P. Reilly, Steven L. McCune, Toshio Asakura, Tim M. Townes> ;The Journal of Biological Chemistry. 2004 Jun 25
• 32 citations
  Alemtuzumab in relapsed or refractory chronic lymphocytic leukemia and prolymphocytic leukemia.
  Steven L. Mccune, Jon P. Gockerman, Joseph O. Moore, Carlos M. DeCastro, Adam J. Bass, Nelson J. Chao, Gwynn D. Long, James J. Vredenburgh, Cristina Gasparetto, Donna ...> ;Leukemia & Lymphoma. 2002 May 1
• 10 citations
  Monoclonal Antibody Therapy in the Treatment of Non-Hodgkin Lymphoma
  Steven L. Mccune, Jon P. Gockerman, David A. Rizzieri> ;JAMA. 2001 Sep 12
• 212 citations
  Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase
  Wen Yong Chen, Evans C. Bailey, Steven L. McCune, Jian-Yun Dong, Tim M. Townes> ;Proceedings of the National Academy of Sciences of the United States of America. 1997 May 27
• 22 citations
  Stable transduction of recombinant adeno-associated virus into hematopoietic stem cells from normal and sickle cell patients.
  Lubovy M, Steven L. McCune, Dong Jy, J F Prchal, Tim M. Townes, Josef T. Prchal> ;Biology of Blood and Marrow Transplantation. 1996 Feb 1
• 30 citations
  Retroviral vector sequences inhibit human beta-globin gene expression in transgenic mice.
  Steven L. McCune, Tim M. Townes> ;Nucleic Acids Research. 1994 Oct 25
• 46 citations
  Recombinant human hemoglobins designed for gene therapy of sickle cell disease
  Steven L. McCune, Michael P. Reilly, Matthew J. Chomo, Toshio Asakura, Tim M. Townes> ;Proceedings of the National Academy of Sciences of the United States of America. 1994 Oct 11
• 8 citations
  Preparation of recombinant hemoglobin in transgenic mice.
  Michael P. Reilly, Steven L. McCune, Thomas M. Ryan, Tim M. Townes, Makoto Katsumata, Toshio Asakura> ;Methods in Enzymology. 1994 Jan 1
• 12 citations
  The centromere and aneuploidy: I. Caffeine-induced detachment and fragmentation of kinetochores of mammalian chromosomes.
  Raymond P. Zinkowski, McCune Sl, Balczon Rd, Potu N. Rao, Brinkley Br> ;Progress in Clinical and Biological Research. 1989 Jan 1
• 11 citations
  The centromere and aneuploidy: I. Caffeine-induced detachment and fragmentation of kinetochores of mammalian chromosomes.
  Raymond P. Zinkowski, McCune Sl, Balczon Rd, Potu N. Rao, Brinkley Br> ;Progress in Clinical and Biological Research. 1989 Jan 1
• Join now to see all